These Stocks Are Moving the Most Today: Metsera, Nvidia, Tesla, Rumble, MP Materials, ViaSat, Monday.com, CoreWeave, and More

Stocks gained Monday, with the S&P 500 and Nasdaq Composite each rising over 1%, as investors remained hopeful that the ...

Metsera falls after accepting up to $10 billion sweetened buyout offer from Pfizer

Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a sweetened ...
BioSpace

Pfizer’s Winning Bid For Metsera Concludes ‘Real Housewives of Biopharma’

“No need for a reunion show: This seasons Real Housewives of Biopharma comes to a close with Pfizer’s winning bid for Metsera ...
PharmExec

Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer

On November 4, 2025, just a day after Pfizer filed its suits against Novo Nordisk and Metsera, Novo Nordisk submitted an ...

Metsera (MTSR) Shares Nosedive After Pfizer Clinches Weight-Loss Biotech Deal

Metsera said it has struck a revised merger agreement with Pfizer that values the company at up to $86.25 per share in cash.

Pfizer's move for Metsera adds to busy year of healthcare M&A. But the sector's in a rut.

Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...

Stocks to Watch Monday: Barrick Mining, TSMC, Metsera, Tyson Foods

The contract chip maker's sales rose last month at the slowest pace since February 2024, but [remained in double-digits]( ...

Pfizer Gets Metsera: Why The $20.65 CVR Is Highly Likely To Pay Out (In Part)

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

Metsera shares fell sharply in premarket trading Monday after the weight-loss drug startup struck a revised deal to be acquired by Pfizer, prompting Danish drugmaker Novo Nordisk to drop out of a ...